Atem Nebuliser Solution (Ipratropium Bromide) – Chiesi

CONTENTS:
Ipratropium Bromide 500mcg/UDV

FORM:
Unit Dose Vials (UDV’s)

INDICATIONS:
For the treatment of bronchial asthma, chronic obstructive bronchopneumopathy with asthmatic component.

Atem® 0.025% Nebuliser Solution
Each 2ml vial of Atem contains sterile Solution for nebulization – Ipratropium Bromide 500mcg Ipratropium bromide is a competitive antagonist of muscarinic acetylcholine receptors. It exhibits its greatest potency on bronchial receptors, whether given inhaled or through nebulizer but causes no tachycardia. No anticholinergic effects have been observed on cardiac function.